These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 31757209)

  • 1. MiRNA therapeutics based on logic circuits of biological pathways.
    Boscaino V; Fiannaca A; La Paglia L; La Rosa M; Rizzo R; Urso A
    BMC Bioinformatics; 2019 Nov; 20(Suppl 9):344. PubMed ID: 31757209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systems biology approach for miRNA-mRNA expression patterns analysis in non-small cell lung cancer.
    Najafi A; Tavallaei M; Hosseini SM
    Cancer Biomark; 2016; 16(1):31-45. PubMed ID: 26484609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA methylation of microRNA-coding genes in non-small-cell lung cancer patients.
    Heller G; Altenberger C; Steiner I; Topakian T; Ziegler B; Tomasich E; Lang G; End-Pfützenreuter A; Zehetmayer S; Döme B; Arns BM; Klepetko W; Zielinski CC; Zöchbauer-Müller S
    J Pathol; 2018 Aug; 245(4):387-398. PubMed ID: 29570800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miRNA and cancer; computational and experimental approaches.
    Tutar Y
    Curr Pharm Biotechnol; 2014; 15(5):429. PubMed ID: 25189575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reproducible combinatorial regulatory networks elucidate novel oncogenic microRNAs in non-small cell lung cancer.
    Mitra R; Edmonds MD; Sun J; Zhao M; Yu H; Eischen CM; Zhao Z
    RNA; 2014 Sep; 20(9):1356-68. PubMed ID: 25024357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrative analysis reveals disrupted pathways regulated by microRNAs in cancer.
    Wilk G; Braun R
    Nucleic Acids Res; 2018 Feb; 46(3):1089-1101. PubMed ID: 29294105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNAs: an overview on miRNA sponging and its co-regulation in lung cancer.
    Rajakumar S; Jamespaulraj S; Shah Y; Kejamurthy P; Jaganathan MK; Mahalingam G; Ramya Devi KT
    Mol Biol Rep; 2023 Feb; 50(2):1727-1741. PubMed ID: 36441373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of key microRNAs and hub genes in non-small-cell lung cancer using integrative bioinformatics and functional analyses.
    Song F; Xuan Z; Yang X; Ye X; Pan Z; Fang Q
    J Cell Biochem; 2020 Mar; 121(3):2690-2703. PubMed ID: 31692035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The expression of circulating miR-504 in plasma is associated with EGFR mutation status in non-small-cell lung carcinoma patients.
    Szpechcinski A; Florczuk M; Duk K; Zdral A; Rudzinski S; Bryl M; Czyzewicz G; Rudzinski P; Kupis W; Wojda E; Giedronowicz D; Langfort R; Barinow-Wojewodzki A; Orlowski T; Chorostowska-Wynimko J
    Cell Mol Life Sci; 2019 Sep; 76(18):3641-3656. PubMed ID: 30953094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-Wide Small RNA Sequencing Identifies MicroRNAs Deregulated in Non-Small Cell Lung Carcinoma Harboring Gain-of-Function Mutant p53.
    Datta A; Das P; Dey S; Ghuwalewala S; Ghatak D; Alam SK; Chatterjee R; Roychoudhury S
    Genes (Basel); 2019 Oct; 10(11):. PubMed ID: 31661871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-based therapeutics for cancer.
    Wang V; Wu W
    BioDrugs; 2009; 23(1):15-23. PubMed ID: 19344188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miRNA and Proteomic Dysregulation in Non-Small Cell Lung Cancer in Response to Cigarette Smoke.
    Babu N; Advani J; Solanki HS; Patel K; Jain A; Khan AA; Radhakrishnan A; Sahasrabuddhe NA; Mathur PP; Nair B; Keshava Prasad TS; Chang X; Sidransky D; Gowda H; Chatterjee A
    Microrna; 2018; 7(1):38-53. PubMed ID: 29299995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A mathematical model for microRNA in lung cancer.
    Kang HW; Crawford M; Fabbri M; Nuovo G; Garofalo M; Nana-Sinkam SP; Friedman A
    PLoS One; 2013; 8(1):e53663. PubMed ID: 23365639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamical Analysis of a Boolean Network Model of the Oncogene Role of lncRNA ANRIL and lncRNA UFC1 in Non-Small Cell Lung Cancer.
    Gupta S; Hashimoto RF
    Biomolecules; 2022 Mar; 12(3):. PubMed ID: 35327612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiRSEA: Discovering the pathways regulated by dysfunctional MicroRNAs.
    Han J; Liu S; Zhang Y; Xu Y; Jiang Y; Zhang C; Li C; Li X
    Oncotarget; 2016 Aug; 7(34):55012-55025. PubMed ID: 27474169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA therapeutics: towards a new era for the management of cancer and other diseases.
    Rupaimoole R; Slack FJ
    Nat Rev Drug Discov; 2017 Mar; 16(3):203-222. PubMed ID: 28209991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A densely interconnected genome-wide network of microRNAs and oncogenic pathways revealed using gene expression signatures.
    Ooi CH; Oh HK; Wang HZ; Tan AL; Wu J; Lee M; Rha SY; Chung HC; Virshup DM; Tan P
    PLoS Genet; 2011 Dec; 7(12):e1002415. PubMed ID: 22194702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-182-5p and its target HOXA9 in non-small cell lung cancer: a clinical and in-silico exploration with the combination of RT-qPCR, miRNA-seq and miRNA-chip.
    Gao L; Yan SB; Yang J; Kong JL; Shi K; Ma FC; Huang LZ; Luo J; Yin SY; He RQ; Hu XH; Chen G
    BMC Med Genomics; 2020 Jan; 13(1):3. PubMed ID: 31906958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using biological information to analyze potential miRNA-mRNA regulatory networks in the plasma of patients with non-small cell lung cancer.
    Zhang W; Zhang Q; Che L; Xie Z; Cai X; Gong L; Li Z; Liu D; Liu S
    BMC Cancer; 2022 Mar; 22(1):299. PubMed ID: 35313857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-modulated autophagic signaling networks in cancer.
    Fu LL; Wen X; Bao JK; Liu B
    Int J Biochem Cell Biol; 2012 May; 44(5):733-6. PubMed ID: 22342941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.